These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

818 related articles for article (PubMed ID: 9205097)

  • 1. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator.
    Eliopoulos AG; Dawson CW; Mosialos G; Floettmann JE; Rowe M; Armitage RJ; Dawson J; Zapata JM; Kerr DJ; Wakelam MJ; Reed JC; Kieff E; Young LS
    Oncogene; 1996 Nov; 13(10):2243-54. PubMed ID: 8950992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRs.
    Hauer J; PĆ¼schner S; Ramakrishnan P; Simon U; Bongers M; Federle C; Engelmann H
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2874-9. PubMed ID: 15708970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
    Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
    Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fusion of the EBV latent membrane protein-1 (LMP1) transmembrane domains to the CD40 cytoplasmic domain is similar to LMP1 in constitutive activation of epidermal growth factor receptor expression, nuclear factor-kappa B, and stress-activated protein kinase.
    Hatzivassiliou E; Miller WE; Raab-Traub N; Kieff E; Mosialos G
    J Immunol; 1998 Feb; 160(3):1116-21. PubMed ID: 9570524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
    Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
    Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation.
    Devergne O; Hatzivassiliou E; Izumi KM; Kaye KM; Kleijnen MF; Kieff E; Mosialos G
    Mol Cell Biol; 1996 Dec; 16(12):7098-108. PubMed ID: 8943365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain.
    Huen DS; Henderson SA; Croom-Carter D; Rowe M
    Oncogene; 1995 Feb; 10(3):549-60. PubMed ID: 7845680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus and a cellular signaling pathway in lymphomas from immunosuppressed patients.
    Liebowitz D
    N Engl J Med; 1998 May; 338(20):1413-21. PubMed ID: 9580648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappaB activation in CD27 signaling: involvement of TNF receptor-associated factors in its signaling and identification of functional region of CD27.
    Yamamoto H; Kishimoto T; Minamoto S
    J Immunol; 1998 Nov; 161(9):4753-9. PubMed ID: 9794406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.
    Miller WE; Cheshire JL; Baldwin AS; Raab-Traub N
    Oncogene; 1998 Apr; 16(14):1869-77. PubMed ID: 9583684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.
    Pullen SS; Labadia ME; Ingraham RH; McWhirter SM; Everdeen DS; Alber T; Crute JJ; Kehry MR
    Biochemistry; 1999 Aug; 38(31):10168-77. PubMed ID: 10433725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: contrasting roles of TNF receptor-associated factor 2 (TRAF2) and TRAF3 in CD40-activated B lymphocyte differentiation.
    Hostager BS; Bishop GA
    J Immunol; 1999 Jun; 162(11):6307-11. PubMed ID: 10352240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus encoded latent membrane protein 1 induces TRAF1 expression to promote anti-apoptosis activity via NF-kappaB signaling pathway in nasopharyngeal carcinoma.
    Wang C; Ai M; Ren W; Xiao H; Li X; Tang F; Gu H; Yi W; Weng X; Deng X; Cao Y
    Chin Med J (Engl); 2003 Jul; 116(7):1022-8. PubMed ID: 12890376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF receptor-associated factor-3 signaling mediates activation of p38 and Jun N-terminal kinase, cytokine secretion, and Ig production following ligation of CD40 on human B cells.
    Grammer AC; Swantek JL; McFarland RD; Miura Y; Geppert T; Lipsky PE
    J Immunol; 1998 Aug; 161(3):1183-93. PubMed ID: 9686578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
    Hsing Y; Hostager BS; Bishop GA
    J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
    Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
    Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.